BIOPHARM FORWARD ApS — Credit Rating and Financial Key Figures
CVR number: 32438784
Gammel Strandvej 442 A, 3060 Espergærde
johi@biopharmforward.dk
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 181.88 | 928.01 | 584.10 | 549.85 | 1 056.75 |
| Employee benefit expenses | - 253.72 | - 305.87 | - 679.49 | - 725.43 | |
| EBIT | 181.88 | 674.28 | 278.23 | - 129.64 | 331.32 |
| Other financial income | 5.37 | 1 075.60 | 70.66 | 35.68 | 171.67 |
| Other financial expenses | -0.21 | -9.89 | - 148.62 | -43.54 | -9.44 |
| Pre-tax profit | 187.03 | 1 739.99 | 200.28 | - 137.50 | 493.56 |
| Income taxes | -41.14 | - 283.14 | -44.15 | 30.20 | - 108.49 |
| Net earnings | 145.89 | 1 456.85 | 156.13 | - 107.30 | 385.06 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Investments total | |||||
| Long term receivables total | |||||
| Inventories total | |||||
| Current trade debtors | 128.13 | ||||
| Current other receivables | 3.18 | ||||
| Current deferred tax assets | 116.86 | 188.09 | 134.90 | 87.48 | |
| Short term receivables total | 116.86 | 191.27 | 134.90 | 215.60 | |
| Other current investments | 16.50 | 1 080.46 | 993.64 | 978.97 | 1 150.09 |
| Cash and bank deposits | 537.17 | 591.07 | 643.82 | 587.86 | 691.94 |
| Cash and cash equivalents | 553.67 | 1 671.54 | 1 637.46 | 1 566.84 | 1 842.03 |
| Balance sheet total (assets) | 553.67 | 1 788.40 | 1 828.73 | 1 701.74 | 2 057.63 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 131.25 | 131.25 | 131.25 | 131.25 | 131.25 |
| Shares repurchased | 114.40 | 117.80 | 122.00 | 135.00 | |
| Retained earnings | -68.02 | - 149.53 | 1 189.52 | 1 223.64 | 981.34 |
| Profit of the financial year | 145.89 | 1 456.85 | 156.13 | - 107.30 | 385.06 |
| Shareholders equity total | 209.12 | 1 552.97 | 1 594.69 | 1 369.59 | 1 632.65 |
| Non-current deferred tax liabilities | 78.30 | ||||
| Non-current liabilities total | 78.30 | ||||
| Current trade creditors | 6.60 | 6.60 | 6.60 | 25.66 | 6.60 |
| Current owed to participating | 263.75 | 218.14 | 226.87 | 235.94 | 245.38 |
| Short-term deferred tax liabilities | 53.28 | ||||
| Other non-interest bearing current liabilities | 20.91 | 10.69 | 0.57 | 70.54 | 94.70 |
| Current liabilities total | 344.55 | 235.43 | 234.04 | 332.15 | 346.68 |
| Balance sheet total (liabilities) | 553.67 | 1 788.40 | 1 828.73 | 1 701.74 | 2 057.63 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.